Home » GE Healthcare, DoveBid Expand Life Sciences Asset Disposal Capabilities
GE Healthcare, DoveBid Expand Life Sciences Asset Disposal Capabilities
PharmaManufacturing.com
11/02/2009
October 20th, 2009 - GE Healthcare, a unit of General Electric Company, has formed a strategic collaboration with GoIndustry DoveBid. The partnership enhances GE Healthcare's asset disposal capabilities and expands its ability to provide critical business intelligence to customers by providing data from GoIDB as an integrated part of its Scientific Asset Services (SAS) programs. The collaboration will allow GE Healthcare to provide its customers with advice on residual value, life span, market trends and best practice in disposal of scientific equipment. Customers will also benefit from a rapid route to dispose of surplus or under-utilized equipment, releasing capital back into their businesses.
"This industry-leading collaboration will enhance our asset life cycle management solution," says Mike Benevento, GM Services, GE Healthcare. "With the data provided by GoIDB we can ensure that our customers receive the intelligence they need to enable them to make confident and informed decisions on what to do with their underutilized or obsolete assets, unlocking some capital into their operations." Jack G. Reinelt, CEO at GoIDB commented: "We are excited about this opportunity to work with GE Healthcare. Our unique position within the second-hand equipment market enables us to provide GE Healthcare's customers with up-to-date asset market data plus the ability to dispose of surplus equipment through our well-established auctions guaranteeing customers the best return." For more information please visit: www.gelifesciences.com/sas
More News:
- 02/08/2010 EMA 'Road Map' Outlines Supply Chain Security Plans
- 02/08/2010 One-Third of Antimalarial Medicines Sampled in Three African Nations Found to be Substandard in Large-Scale USP-WHO Study
- 02/05/2010 FDA Aims to Identify Risky Food, Drug ImportsFrom MSNBC.com
- 02/04/2010 Bristol-Myers Squibb to Freeze Salaries in 2010From WSJ.com
- 02/03/2010 Lilly Transfers Funds, Technology to Aspen in TB Partnership
- 02/03/2010 Teva, Amgen Duke It Out Over Generic BiotechFrom WSJ.com
- 02/02/2010 A Cause for Optimism: Global Manufacturing Surges
- 01/28/2010 Novartis’s Jimenez Beats Out Reinhardt to Replace CEO VasellaFrom BusinessWeek.com
- 01/28/2010 Register For Stevens Institute of Technology’s Spring II 2010 Semester
- 01/28/2010 AstraZeneca to Cut 8,000 Jobs Amid Weak EarningsFrom ABCNews.com
- All news »
Get Connected Now!
- Featured White Papers

Print page